Chitaranjan Mishra

Chitaranjan Mishra

Auto-generated profile, based on publicly available information

Chitaranjan Mishra

Department of Vitreo-Retina, Aravind Eye Hospital, Madurai, India

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Progress in Retinal and Eye Research
Verified
Journal Article
Closed access
RARupesh Agrawal
Rupesh Agrawal
JDJianbin Ding
Jianbin Ding
PSParveen Sen
Parveen Sen
ARAndres Rousselot
Andres Rousselot
ACAmy Chan
Amy Chan
VGVishali Gupta
Vishali Gupta

11 December 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CGChanda Gupta
Chanda Gupta
RTRoy Tan
Roy Tan
CMChitaranjan Mishra
Chitaranjan Mishra
NKNeha Khandelwal
Neha Khandelwal
RRRajiv Raman
Rajiv Raman
PSParveen Sen
Parveen Sen
To evaluate structural changes in the choroid among patients with diabetic macular edema (DME), with varying grades of diabetic retinopathy (DR), using enhance depth imaging spectral domain optical coherence tomography (EDI SD-OCT) scans. A cross-sectional study was conducted on 82 eyes with DR and DME and 86 healthy control eyes. Eyes with DME were classified according to the severity of DR as per the international DR severity scale. Sub foveal choroidal thickness (SFCT)was obtained using EDI SD-OCT scans. These scans were binarized into luminal and stromal areas, to derive the choroidal vascularity index (CVI). CVI and SFCT were analyzed between the study and control group using paired-T test. Tukey’s test was used to correlate the differences in CVI and SFCT between different grades of DR. Further analysis was done to look for the effect of DR severity and type of DME on CVI as well as SFCT using correlation coefficient and linear regression analysis. SFCT was significantly increased in eyes with DME as compared to the controls (334.47±51.81μm vs 284.53±56.45μm, p<0.001), and showed an ascending trend with worsening of DR, though this difference was not statistically significant [mild non-proliferative diabetic retinopathy (NPDR) = 304.33±40.39μm, moderate NPDR = 327.81±47.39μm, severe NPDR = 357.72±62.65μm, proliferative DR (PDR) = 334.59±47.4μm, p-0.09]. CVI was significantly decreased in DME with DR eyes as compared to controls (63.89±1.89 vs 67.51±2.86, p<0.001). CVI was also significantly decreased with worsening DR (mild NPDR = 66.38±0.3, moderate NPDR = 65.28±0.37, severe NPDR = 63.50±0.47, PDR = 61.27±0.9, p<0.001). SFCT and CVI are dynamic parameters that are affected by DME. Unlike CVI, SFCT is also affected by ocular and systemic factors like edema and hypertension. CVI may be a more accurate surrogate marker for DME and DR and can potentially be used to monitor the progression of DR.

4 September 2018 in Acta Ophthalmologica
Verified
Journal Article
Open access
PDF file
XWXin Wei
Xin Wei
CMChitaranjan Mishra
Chitaranjan Mishra
NKNaresh Babu Kannan
Naresh Babu Kannan
GHGraham E. Holder
Graham E. Holder
NKNeha Khandelwal
Neha Khandelwal
RARupesh Agrawal
Rupesh Agrawal
Purpose: To assess choroidal structural changes in patients with retinal dystrophies using choroidal vascularity index (CVI), a novel optical coherence tomography (OCT) based tool.Methods: This retrospective study included 26 patients with retinal dystrophies (17 with retinitis pigmentosa, four with Stargardt disease, three with cone‐rod dystrophy, one each with Best disease and Bietti crystalline dystrophy) and 32 healthy controls. Subfoveal OCT images were used for analysis. Mean CVI was compared between retinal dystrophy and control group, as well as among the retinal dystrophy subgroups.Results: Mean CVI in eyes with retinal dystrophies was 52 ± 9% and it was significantly lower compared to that in normal eyes (70 ± 3%, p < 0.001). The differences among subgroups of retinal dystrophy were not statistically significant (p = 0.084). All types of retinal dystrophy were associated with lower CVI (all p < 0.001), after adjusting for age, gender, visual acuity and duration of symptoms. Older age was also shown to be independently associated with lower CVI (p = 0.012). Gender, visual acuity (VA) and duration of symptoms did not significantly affect CVI.Conclusion: Decreased choroidal vascularity was seen in eyes with retinal dystrophies. (CVI) may be a helpful tool in monitoring choroidal involvement in retinal dystrophies.

13 February 2018 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
CMChitaranjan Mishra
Chitaranjan Mishra
PLPrajna Lalitha
Prajna Lalitha
GRGunasekaran Rameshkumar
Gunasekaran Rameshkumar
RARupesh Agrawal
Rupesh Agrawal
PBPraveen Kumar Balne
Praveen Kumar Balne
KRKim Ramasamy
Kim Ramasamy
Purpose: To report the incidence and characteristics of endophthalmitis after intravitreal injections (IVI) of antivascular endothelial growth factor agents and triamcinolone acetonide. Methods: Patients’ medical records were retrospectively reviewed from January 2009 to June 2016, and the incidence, risk factors, clinical and microbiological characteristics of post-IVI endophthalmitis were evaluated. Results: The total number of intravitreal injections given, which included ranibizumab, bevacizumab, and triamcinolone acetonide, was 20,566, of which 27 cases developed endophthalmitis, giving an overall incidence of 0.131%. Significant reduction (p < 0.003) in incidence of endophthalmitis was observed in patients who received prefilled compounded bevacizumab injections (0.050%) compared to multiple bevacizumab injections from a single vial (0.235%). In the triamcinolone acetonide group, the incidence was 0.26%. Staphylococcus species were isolated from 18 cases (67%), and all strains were sensitive to vancomycin. Conclusions: Adherence to strict aseptic protocols and use of prefilled compounded bevacizumab injections reduces the rate of post-IVI endophthalmitis.

1 March 2018 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
XWXin Wei
Xin Wei
SSShozo Sonoda
Shozo Sonoda
CMChitaranjan Mishra
Chitaranjan Mishra
NKNeha Khandelwal
Neha Khandelwal
RKRamasamy Kim
Ramasamy Kim
RARupesh Agrawal
Rupesh Agrawal
Purpose: To compare the agreement between optical coherence tomography (OCT)-based choroidal vascularity markers measured by two previously reported image binarization techniques. Methods: Spectral-domain OCT using enhanced-depth imaging was performed in 100 eyes from 52 normal subjects. Choroidal images were binarized to luminal area and stromal area using two different algorithms. Choroidal vascularity marker was defined as the ratio of luminal area to total choroidal area and they were termed “luminal/choroidal area ratio (L/C ratio)” and “choroidal vascularity index (CVI)” per the algorithm. The agreement between choroidal vascularity markers measured by the two techniques was compared using intraclass correlation coefficient (ICC) and Bland-Altman analysis. Results: The mean values of choroidal vascularity markers were 70.12% (range, 56.76%–78.55%) for CVI and 67.44% (range, 51.09%–81.31%) for L/C ratio. Low level of absolute agreement between the two binarization techniques was reflected by an adjusted ICC of 0.353 using linear mixed model with age, sex, and spherical equivalent as covariates. Conclusions: There was discrepancy between measurements of choroidal vascularity using two commonly adopted image binarization techniques. It remained unclear what was the true choroidal vascularity and which binarization algorithm was more accurate. Future studies with enhanced image quality and improved image analysis algorithm are required to decipher the ground truth for choroidal vascularity.

26 June 2021 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
AHAnnette K. Hoskin
Annette K. Hoskin
RLRebecca Low
Rebecca Low
PSParveen Sen
Parveen Sen
CMChitaranjan Mishra
Chitaranjan Mishra
TKTengku Ain Kamalden
Tengku Ain Kamalden
RARupesh Agrawal
Rupesh Agrawal